Luckwel Pharmaceuticals Inc. announced earnings results for the second quarter ended September 30, 2019. For the second quarter, the company announced net loss was USD 111,387 compared to USD 159,099 a year ago. Basic loss per share from continuing operations was USD 0.001 compared to USD 0.001 a year ago. For the half year, net loss was USD 251,901 compared to USD 379,452 a year ago. Basic loss per share from continuing operations was USD 0.002 compared to USD 0.003 a year ago.